Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
- 17 September 1999
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 155 (1-2) , 143-152
- https://doi.org/10.1016/s0303-7207(99)00117-3
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoterOncogene, 1999
- Gene Amplification and Overexpression of CDK4 in Sporadic Breast Carcinomas Is Associated with High Tumor Cell ProliferationThe American Journal of Pathology, 1999
- Stable Interaction between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic CellsMolecular Cell, 1998
- Survival in early-onset BRCA1 breast-cancer patientsThe Lancet, 1998
- BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase ANature Genetics, 1998
- Interaction of p53 with the Human Rad51 ProteinNucleic Acids Research, 1997
- p53 mutations in BRCA1-associated familial breast cancerThe Lancet, 1997
- Double indemnity: p53, BRCA and cancerNature Medicine, 1997
- Transcriptional activation by BRCA1Nature, 1996
- High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from BRCAI‐linked familiesGenes, Chromosomes and Cancer, 1995